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Biofilm infection is now understood to be a potent contributor to the recalcitrant
nature of chronic wounds. Bacterial biofilms evade the host immune response
and show increased resistance to antibiotics. Along with improvements in antibiotic
stewardship, effective new anti-biofilm therapies are urgently needed for effective wound
management. Previous studies have shown that bioactive glass (Bg) is able to promote
healing with moderate bactericidal activity. Here we tested the antimicrobial efficacy of
a novel BG incorporating silver (BgAg), against both planktonic and biofilm forms of the
wound-relevant bacteria Pseudomonas aeruginosa and Staphylococcus aureus. BgAg
was stable, long lasting, and potently effective against planktonic bacteria in time-kill
assays (6-log reduction in bacterial viability within 2 h) and in agar diffusion assays. BgAg
reduced bacterial load in a physiologically relevant ex vivo porcine wound biofilm model;
P. aeruginosa (2-log reduction) and S. aureus (3-log reduction). BgAg also conferred
strong effects against P. aeruginosa biofilm virulence, reducing both protease activity and
virulence gene expression. Co-culture biofilms appeared more resistant to BgAg, where
a selective reduction in S. aureus was observed. Finally, BgAg was shown to benefit
the host response to biofilm infection, directly reducing host tissue cell death. Taken
together, the findings provide evidence that BgAg elicits potent antimicrobial effects
against planktonic and single-species biofilms, with beneficial effects on the host tissue
response. Further investigations are required to elucidate the specific consequences
of BG administration on polymicrobial biofilms, and further explore the effects on
host–microbe interactions.
Keywords: biofilm, bioactive glass, wound healing, Pseudomonas aeruginosa, Staphylococcus aureus
INTRODUCTION
Breaches to the skin barrier must be repaired in a timely and efficient manner to prevent
infection and wound persistence (Bjarnsholt et al., 2008). Unfortunately, healing often fails,
leading to chronic, non-healing wounds. Chronic wounds affect millions of patients annually, with
associated substantial costs to healthcare providers (Posnett and Franks, 2008; Gould et al., 2015).
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In recent years, one of the most discussed extrinsic contributors
to wound chronicity has been the presence of infection,
particularly critical colonization by pathogenic organisms
existing as biofilms (Dow et al., 1999; James et al., 2008; Wolcott
et al., 2015). Biofilms are bacterial aggregates able to evade
host responses and develop rapid pathogenicity (reviewed in
Gellatly and Hancock, 2013; Flemming et al., 2016). They are
encapsulated in self-produced extracellular polymeric substances
(EPS), which provide a protective barrier against both host
defenses and exogenous antibiotic treatments (Flemming and
Wingender, 2010). Moreover, biofilms consist of heterogeneous
communities which allows inter-specific transfer of metabolites
and antimicrobial-resistance genes, thus increasing overall
bacterial virulence (Leid et al., 2005; Mah, 2012). Sadly, wound
infection is on the rise, with the prevalence of antibiotic-resistant
bacterial strains and the persistence of biofilms contributing
to the recalcitrant nature of chronic wounds (Velnar et al.,
2009). Antibiotic resistance is not only a problem for wound
management but a widespread threat to human health, claiming
in excess of 50,000 lives in western society alone (O’Neill, 2014).
Consequently, the implementation of antibiotic stewardship
programs worldwide aim to prevent misuse thus reducing
antibiotic resistance and improving patient outcome (Bowler,
2018).
Bioactive materials are a concept first introduced by L. L.
Hench, who stated that the main requirement of a bioactive
material was to elicit a biological response at the interface
between the material and the living tissue (Hench, 2006).
Bioactive glass (BG) has emerged as one such bioactive material,
which has the potential to promote dental and bone repair.
BG compositions can include compounds with known pro-
healing effects (e.g., CaO, SiO2, P2O5, and MgO; Lin et al.,
2012). BGs bond compatibly to tissues via dissolution and
precipitation reactions that actuate surface ion exchange. In
damaged bone tissue, BG ion release increases pH, causing the
formation of a hydroxycarbonate apatite (HCA) interface layer,
which mimics the type of scaffold that would naturally form
during tissue repair (Hench, 2006). This HCA interface then
promotes cell migration, osteoprogenitor differentiation (Jones,
2013; Miguez-Pacheco et al., 2015) and ultimately accelerates
bone matrix reformation (as assessed in Maçon et al., 2017).
Interestingly, elevated alkalinity can provide a bactericidal
environment, thus BG alone may have antibacterial effects
(Zehnder et al., 2006). BGs can also be used as a substrate for
incorporating known antimicrobials, such as metal nanoparticles
(Gholipourmalekabadi et al., 2016).
Silver (Ag) and silver nanoparticles (AgNPs) exhibit potent
antimicrobial efficacy against a range of bacterial species
(Ruparelia et al., 2008), including antibiotic-resistant strains
(Mekkawy et al., 2017; Tiwari et al., 2017a,b) and established
biofilms (Ueno et al., 2016) in experimental settings. In the
clinic, the evidence for silver efficacy is less robust, underpinning
variability in clinical use (Rodriguez-Arguello et al., 2018).
Incorporating Ag and AgNPs into BG has been suggested as a
potential alternative to antibiotics for reducing infection in a
range of clinical applications (Zhao et al., 2015). TheraglassTM
(Theraglass Ltd., United Kingdom) is a novel, highly bioactive,
binary (SiO2 and CaO) sol–gel derived BG (Saravanapavan and
Hench, 2001; Bellantone et al., 2002; Poologasundarampillai et al.,
2014; Maçon et al., 2015). Advantages of sol–gel derived BG over
more traditional melt-derived BG include easier manufacturing
processes and higher purity (Saravanapavan and Hench, 2001).
TheraglassTM also exhibits a larger surface area to volume ratio
than other BG formulations, which may convey higher overall
bioactivity (Maçon et al., 2015). One formulation of TheraglassTM
also incorporates silver (AgO) hence it maintains high potential
as an antimicrobial therapeutic.
In the present study, we aimed to elucidate the antimicrobial
and anti-biofilm efficacy of a novel, highly bioactive, binary sol–
gel derived AgO-functionalized BG (TheraglassTM) against the
opportunistic wound pathogens Pseudomonas aeruginosa and
Staphylococcus aureus.
MATERIALS AND METHODS
Bioactive Glass Formulations
The elemental composition of TheraglassTM by mol% is 70
SiO2:30 CaO, while TheraglassTM Ag contains 70 SiO2:28
Ca:2 AgO by mol%. Topical treatments were prepared from
powders containing BG (TheraglassTM; “Bg”) and BG containing
silver (TheraglassTM Ag; “BgAg”), mixed with a vehicle (Nivea,
Beiersdorf) to produce BG preparations at a 20% (w/v) working
concentration. A 2% (w/v) silver (AgO) control (“Ag”) was
included, at the equimolar concentration of AgO in BgAg, by
mixing the vehicle with AgO. For all experiments, except stability
and kinetics testing, treatments were prepared and applied fresh
(i.e., immediately post-mixing).
Bacterial Cell Culture
Clinical reference strains of P. aeruginosa (NCTC 10781) and
S. aureus (NCTC 13297) were chosen in this study because
of their direct relevance in chronic wound infection (Price
et al., 2009). Bacterial stocks stored at −80◦C in glycerol were
streaked onto Mueller–Hinton agar (MHA; Oxoid) plates and
incubated for 24 h at 37◦C to produce viable colonies. Overnight
(O/N) cultures were prepared by incubating a single bacterial
colony in 10 ml Mueller–Hinton broth (MHB; Oxoid) for
16 h at 37◦C with 140 rpm shaking (Labnet 211DS shaking
incubator, Labnet International). For all assays, O/N cultures
were adjusted to 0.5 on the McFarland turbidity scale as described
in Balouiri et al. (2016) unless otherwise stated. Briefly, bacterial
cultures were diluted in 0.85% (w/v) sterile saline and adjusted
to an optical density (OD) of 0.08–0.12 at 625 nm using
a spectrophotometer (Jenway 7310, Cole-Parmer). Adjusted
bacterial suspensions were further diluted 1:150 in MHB to give
starting concentrations between 5 × 105 and 1 × 106 colony
forming units per ml (CFU/ml), confirmed by spread plating on
MHA.
Agar Diffusion Testing
Pseudomonas aeruginosa and S. aureus, adjusted to the turbidity
scale described above, were spread onto MHA (200 µl per plate).
Sterile 1 cm2 pieces of TegadermTM pad (3M) were used to apply
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treatments (described above) to MHA plates. A vehicle control
(TegadermTM Pad and Nivea) was also included. Treatments
(n = 3 per group) were incubated at 37◦C for 24 and 48 h.
At the point of collection, plates were imaged with a Nikon
camera (Finepix S5700, Nikon) and growth inhibition zones
were measured in ImageJ v.1.6 (National Institutes of Health,
NIH). Agar diffusion tests were repeated in three independent
experiments.
Time-Kill Assays
Adjusted cultures of P. aeruginosa and S. aureus in MHB were
added to sterile universal tubes (5 ml per tube) with 1 g of
fresh cream treatment (described above). Tubes were incubated
at 37◦C with 140 rpm shaking for 0.5, 1, 2, 3, 6, and 24-h time-
points. Upon collection, 100 µl of bacterial broth was removed
from each tube and added to 900 µl Dey-Engley Neutralizing
broth (DENB; Fluka, Sigma-Aldrich). The DENB was tested prior
to use to ensure it neutralized the antimicrobial treatments under
study (data not shown). Samples were serial diluted, plated on
MHA in duplicate, and incubated for 24 h at 37◦C to determine
CFU/ml. The time-kill assay was repeated in three independent
experiments.
Stability and Kinetics Testing
To test the stability of Ag, Bg, and BgAg, preparations (described
above) were incubated at 4◦C and room temperature (RT) for
24–120 h. At each 24-h interval, treatments were collected for
agar diffusion assays against P. aeruginosa and S. aureus (as
above). To test the kinetics of antimicrobial soluble factor release,
Bg and BgAg (1 g per tube) were incubated in tubes containing
5 ml of Dulbecco’s phosphate buffered saline (DPBS; Gibco,
United Kingdom) at RT on a rocker over a period of 24–144 h,
and collected at 24-h intervals. At each time point, supernatant
(SN) was collected and replaced with fresh DPBS. TegadermTM
Pad was soaked in collected SN and added to bacterial plates for
agar diffusion testing.
Biofilm Formation Tests
Following our investigations of the antimicrobial efficacy of BG
against planktonic bacteria, we tested the ability of BG to inhibit
biofilm formation. Here, a standard 96-well microtiter plate assay
was performed (as described in O’Toole, 2011). Briefly, 50 µl
of MHB was added to each well, with treatments serial diluted
(twofold dilutions) down each row. P. aeruginosa, S. aureus, and
co-cultures (50:50 mix of P. aeruginosa:S. aureus), adjusted to
the 0.5 McFarland standard and diluted as above, were added
to each well (50 µl per well). Plates were incubated under
aerobic conditions at 37◦C for 48 h. After this time, plates
were submerged in dH2O to remove planktonic bacteria, and
125 µl 0.1% (w/v) crystal violet was added to each well for
30 min to stain biofilms. Plates were washed in dH2O and dried
O/N. To solubilize the crystal violet, 200 µl of 30% acetic acid
was added to each well and plate absorbance was measured at
570 nm. Biofilm formation was categorized as in Christensen
(1989) based on the ODs obtained above (see Table 1). The OD
cut-off (ODc) was deduced as three standard deviations above the
TABLE 1 | Optical density classifications used to determine strength of biofilm
production in biofilm formation assays.
OD495 nm value Classification
≤0.04 Non-adherent
>0.04 and ≤0.08 Weak biofilm
>0.08 and ≤0.16 Moderate biofilm
>0.16 Strong biofilm
mean OD of the negative control. Biofilms were then classified as
follows:
OD ≤ ODc = non-adherent
ODc < OD ≤ 2× ODc = weak biofilm
2× ODc < OD ≤ 4× ODc = moderate biofilm
4× ODc < OD = strong biofilm
Ex Vivo Porcine Wound Biofilm Model
To test the effects of BG on established biofilms, an ex vivo
porcine wound biofilm model was employed (as in Wilkinson
et al., 2016). Adjusted bacteria were added in 20 µl droplets
to sterile nylon filter membranes (Merck-Millipore) on MHA
and biofilms were left to form at the air-filter interface
for 72 h at 37◦C. Every 24 h, membrane biofilms were
transferred to fresh MHA plates. For co-culture experiments,
planktonic cultures of P. aeruginosa and S. aureus were mixed
in a 1:1 ratio and added to filter membranes as above.
Next, fresh porcine skin, collected under University ethical
approval (FEC_21_2017) from a local abattoir, was held in
high glucose Dulbecco’s Modified Eagle’s Medium (HG DMEM,
Gibco) containing 10% (v/v) fetal bovine serum (FBS; Gibco),
100 U/ml penicillin–streptomycin (Gibco), 10 µg/ml gentamicin
and 2.5 µg/ml Amphotericin B (both Sigma-Aldrich). The
subcutaneous adipose tissue was removed; the skin was washed in
Hank’s Balanced Salt Solution (HBSS, Sigma-Aldrich) containing
2× Antibiotic–Antimycotic (Gibco), and washed in DPBS prior
to wounding.
The porcine skin was cut into 1 cm2 squares; wounds were
created by complete removal of the epidermis, and were treated
with established biofilms. Absorbent pads were soaked in HG
DMEM containing supplements (as above). A filter membrane
was placed between the absorbent pads and each porcine biofilm
explant to allow nutrient transfer to the skin without submersion
(modified from Stojadinovic et al., 2013). The skin was cultured
at 37◦C and 5% CO2 for 24 h to allow biofilm attachment.
Treatments were then added to each biofilm (as described above),
including non-treated biofilm controls and uninoculated porcine
wound controls.
Porcine Wound Biofilm Collection
Following 24 h of incubation, porcine ex vivo biofilm explants
were bisected at their midpoint, with half wounds collected
for viability counts (CFU/ml), histological analysis, extracellular
protease production (via a colorimetric assay and zymography),
and virulence factor expression.
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Viability Counts
Tissue was cut into pieces (<1 mm) and vortexed in tubes
containing 1 ml MHB and 5 ml sterile borosilicate glass beads
(Sigma-Aldrich) for 3 × 10 s pulses. From each tube, 100 µl of
re-suspended bacteria was removed and serial diluted in 900 µl
DENB, with 100 µl of each dilution spread on MHA plates
(for single species enumeration) or Cetrimide agar (Oxoid) and
Mannitol Salt agar (Oxoid) for co-culture colony counts. Plates
were incubated at 37◦C for 24 h. Colonies were enumerated to
give CFU/sample.
Biofilm Visualization
Samples embedded in optimal cutting temperature media (OCT,
CellPath) were cryo-sectioned at 10 µm. Gram-Twort, Acridine
Orange (AO; Sigma-Aldrich), and Concanavalin A (ConA,
Thermo Fisher Scientific) staining were used to visualize porcine
wound biofilm load. A modified Gram-Twort stain was carried
out. Here, sections were fixed in methanol at −20◦C for 10 min,
stained with Crystal Violet and Gram’s Iodine solutions (both
Sigma-Aldrich), differentiated in 2% (v/v) acetic-alcohol and
counterstained with a 0.2% (w/v) neutral red and 0.2% (w/v) fast
green (9:1) solution (Sigma-Aldrich). Sections were differentiated
again, rapidly dehydrated in 100% ethanol and mounted with
Pertex R© mounting medium (CellPath). Images were captured at
×100 magnification on a Nikon E400 microscope with SPOT
camera (SPOT imaging). For fluorescent visualization, methanol-
fixed sections were incubated in AO solution (2 mg/ml) for 5 min
at RT and rinsed in dH2O, or incubated in ConA (50 µg/ml)
at 4◦C O/N and counterstained with DAPI (Thermo Fisher
Scientific). Mowiol 4-88 (Sigma-Aldrich) containing DABCO
(Thermo Fisher Scientific) was used for mounting. Fluorescent
images were taken on a Zeiss Axio Vert. A1 microscope
with AxioCam| cm1 camera (Carl Zeiss Microscopy Ltd) at
×40 magnification. Gram-Twort biofilm thickness analysis was
performed in ImageJ v.1.6 (NIH).
Zymography
Bacteria isolated from treated porcine biofilms via glass bead
dissociation (described above) were centrifuged at 10,000 × g
and 4◦C for 10 min. The SN fraction (containing extracellular
proteases) was removed, sterile-filtered (0.22 µm, Merck-
Millipore) and stored at −80◦C until use. Gelatin zymography
was performed to assess extracellular protease activity. SN was
run on 7.5% acrylamide gels containing 0.2% (w/v) porcine
skin gelatin (Oxoid) in non-reducing conditions. Precision
Plus ProteinTM KaleidoscopeTM Prestained Protein Standards
(Bio-Rad) were used to determine molecular weights of the
separated proteins in the gel. An MMP9 standard (Thermo Fisher
Scientific) was included as an internal control. Gels, washed in
2.5% (v/v) Triton X-100, and incubated in gelatinase resolving
buffer [1% (v/v) Triton X-100, 50 mM Tris–HCl, 5 mM CaCL2,
and 1 µm ZnCl2 in dH2O with 0.02% (w/v) NaN3] for 24 h
at 37◦C, were stained with 0.2% (w/v) amido black (Thermo
Fisher Scientific) and de-stained with 30% (v/v) acetic acid.
Densitometric analysis of gels was performed in ImageJ v.1.6
(NIH) and relative protease expression determined.
Colorimetric Protease Detection
The Azocasein method (Andrejko et al., 2013) was utilized to
demonstrate total extracellular protease production. Here, 100 µl
SN was added to 100 µl of Azocasein (Sigma-Aldrich) solution
(5 mg/ml in 0.1 M Tris–HCL, pH 8.8) and incubated at 37◦C for
3 h. The reaction was stopped with 10% (v/v) trichloroacetic acid
(25 µl per tube) and samples were centrifuged at 14,000 × g for
15 min at RT. To each well of a 96-well plate, 50µl of 0.5 M NaOH
was added to 50 µl of Azocasein SN in triplicate. NaOH was used
as a blank, bacterial protease (Sigma-Aldrich) was included as a
positive control, and absorbance was measured at 405 nm. For
the Azocasein assay, one protease activity unit was defined as an
absorbance increase (OD405 nm) of 0.02 per hour (Andrejko et al.,
2013).
Virulence Factor Gene Expression
Samples snap frozen in liquid nitrogen were cut into <1 mm
pieces, added to 1 ml InvitrogenTM RNAlaterTM Stabilization
Solution (Thermo Fisher Scientific) and 5 ml sterile borosilicate
glass beads. Biofilm aggregates were dissociated from porcine
skin as above and SN was centrifuged at 4◦C to pellet bacterial
cells. P. aeruginosa cell pellets were re-suspended in Max Bacterial
Enhancement Reagent (Thermo Fisher Scientific) following the
manufacturer’s protocol. RNA was then isolated with TRIzol R©
reagent (Invitrogen, Thermo Fisher Scientific) and the aqueous
phase purified with the PureLink RNA Mini Kit (Invitrogen,
Thermo Fisher Scientific) following manufacturer’s instructions.
RNA quantity was assessed using a Nanodrop spectrophotometer
(Thermo Fisher Scientific), and reverse transcribed with Bioscript
(Bioline). cDNA samples were diluted by three orders of
magnitude and RT-qPCRs were carried out with Takyon
mastermix (Eurogentec) on an IQ5 thermocycler (Bio-Rad
Laboratories Ltd.). Relative expression was normalized using
the housekeeping genes 16S and rpoD. Primer sequences were
as follows: aprA: sense 5′-CTTCAATACGCCGTGGAAGT-3′;
antisense 5′-GCGTCGACGAAGTGGATATT-3′; algD: sense 5′-
ATCAG CATCTTTGGTTTGGG-3′; antisense 5′-CACCAATG
ACTTCATGACCG-3′; lasB: sense 5′-GTCGCAGTACTACAAC
GGCA-3′; antisense 5′-ATTGGCCAACAGGTAGAACG-3′; 16S:
sense 5′-GTGGAAAAGAGCTTCTGGCA-3′; antisense 5′-CTT
CTCGACGATGATTTCCG-3′; and rpoD: sense 5′-GCGACG
GTATTCGAACTTGT-3′; antisense 5′-CGAAGAAGGAAATGG
TCGAG-3′.
Host-Response
Masson’s Trichrome Staining
Porcine skin and wounds were created for assessment of tissue
culture viability. Skin and wounds were prepared as above and
samples were cultured in DMEM containing 10% (v/v) FBS,
at 37◦C and 5% CO2 for 48 h. Explants were then bisected
at their midpoint and (a) embedded in OCT or (b) fixed in
4% (v/v) saline-buffered formalin, processed, and embedded in
paraffin wax. Overall structural assessment was performed with a
modified version of the Goldner (1938) Masson’s trichrome stain.
Sections brought to dH2O were stained in Weigert’s hematoxylin
and Biebrich-Scarlet fuchsin, differentiated in phosphotungstic–
phosphomolybdic acid and counterstained with Aniline Blue
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(all reagents from Sigma-Aldrich). Sections were dehydrated in
100% ethanol and mounted in Pertex R© (CellPath). Brightfield
images were taken as above.
Immunohistochemistry
OCT embedded biofilm wounds, sectioned at 10 µm, were
blocked in appropriate serum and incubated in primary
antibodies O/N at 4◦C. The antibodies used were the early
apoptosis marker, goat anti-caspase 3 (R&D Systems), and
the cell-proliferation marker, mouse anti-Ki67 (Novocastra).
Alexa Fluor conjugated secondary antibodies (Thermo Fisher
Scientific) were used to detect antibody binding. Sections were
counterstained in DAPI and mounted in Mowiol 4-88 with
DABCO (Thermo Fisher Scientific). Fluorescent images were
taken as above using the DAPI, FITC and TEXAS RED filters.
Terminal Deoxynucleotidyl Transferase dUTP Nick
End Labeling
An In Situ Cell Death Detection Kit (Roche) was used for
“TUNEL” staining according to manufacturer’s instructions,
using Proteinase K (Thermo Fisher Scientific) antigen retrieval
prior to enzyme incubation. Fluorescent images were taken as
above.
Picrosirius Red Staining
OCT sections were stained with Picrosirius Red to assess
host matrix damage. Here, red birefringence indicated the
presence of type I collagen, while yellow-green birefringence
demonstrated the presence of type III collagen (Junqueira et al.,
1979). Methanol-fixed sections were incubated in Picrosirius
Red solution (0.5 g Sirius Red in 500 ml saturated picric acid,
Sigma-Aldrich) for 1 h at RT, differentiated in 0.5% (v/v) acetic
acid, dehydrated in ethanol, cleared in xylene and mounted
in Pertex R© (CellPath). Polarized light images were taken on a
Nikon E400 microscope with SPOT camera (SPOT imaging)
using a polarizing filter set (Thermo Fisher Scientific). Analysis
of collagen fiber composition was performed in ImageJ v.1.6
(NIH).
Statistical Analyses
Data are expressed as average values ± standard deviations of
the mean. P-values of less than 0.05 were considered significant.
All statistical tests were performed in R v.3.3.3 (R Development
Core Team, 2017) including the car (Fox and Weisberg, 2011)
package. T-tests and one-way ANOVAs were completed, followed
by Tukey’s HSD (honest significant differences) post hoc tests
where applicable.
RESULTS
Silver Bioactive Glass (BgAg) Elicited
Potent Antimicrobial Efficacy Against
Planktonic Cultures of P. aeruginosa and
S. aureus
Agar diffusion assays with planktonic bacteria revealed
differential effects for non-silver functionalized bioactive glass
(Bg) and AgO-functionalized bioactive glass (BgAg) against
P. aeruginosa and S. aureus (Figures 1A–D). Interestingly, Bg,
which was moderately effective at inhibiting P. aeruginosa
growth, displayed no inhibitory effect on S. aureus. By
contrast, BgAg elicited potent antimicrobial efficacy against both
P. aeruginosa and S. aureus following 24- or 48-h treatments.
The silver treatment alone (Ag), at equimolar concentration to
the silver oxide component of BgAg, exhibited only marginal
(non-significant) antimicrobial efficacy. Next, time-kill assays
were used to define the temporal antimicrobial efficacy of
Bg, BgAg, and Ag. In this assay, all treatments were potently
antimicrobial (statistically significant 6-log reduction within 2 h).
However, interesting species- and treatment-specific differences
were observed. Both Bg and BgAg led to a 6-log reduction in
P. aeruginosa within 30 min, whereas this level of reduction took
60 min for Ag treatment (Figure 1E). S. aureus experiments
revealed even greater differential treatment effects. Here, BgAg
FIGURE 1 | Planktonic agar diffusion (A–D) and time-kill (E,F) assays reveal
differential antimicrobial effects of bioactive glass against P. aeruginosa
(A,C,E) and S. aureus (B,D,F). Inhibition zones (depicted by white, dotted
lines) of agar diffusion assays were significantly greater in the Bg incorporating
silver (BgAg) group compared to treatment with Bg alone (Bg), or a silver
control (Ag). This effect was observed at both 24 and 48 h post-treatment,
against P. aeruginosa (A,C) and S. aureus (B,D), respectively. Interestingly, Bg
significantly inhibited P. aeruginosa growth, but had no effect against
S. aureus at both 24 and 48 h. As expected, the vehicle (Veh) created no
inhibition zones against P. aeruginosa or S. aureus. Time-kill assays further
illustrated disparate effects of Bg and BgAg against P. aeruginosa and
S. aureus. Here, BgAg caused a 6-log reduction in P. aeruginosa (E) and
S. aureus (F) within 30 min and 1 h, respectively. Data show the
mean ± SEM. ∗P < 0.05 and ∗∗∗P < 0.001. Scale bars = 5 mm. Data were
obtained from three independent experiments (n = 3 per treatment).
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alone led to a 6-log reduction in S. aureus within 1 h, while
Bg and Ag took 2 h to achieve similar antimicrobial efficacy
(Figure 1F). In summary, both agar diffusion and time-kill assays
revealed both Bg and BgAg to be potently antimicrobial against
P. aeruginosa, while BgAg maintained greater antimicrobial
efficacy against S. aureus than Bg or Ag alone.
BgAg, but Not Bg, Displays Maintained
Antimicrobial Efficacy Over a Clinically
Meaningful Time Frame
Agar diffusion assays were conducted using treatments that
had been incubated at 4◦C or RT for 24–120 h prior to assay
(Figure 2). When newly constituted BgAg and Ag were pre-
incubated at 4◦C, significant efficacy against P. aeruginosa was
maintained over a period of 120 h. Bg on the other hand,
maintained efficacy for only 72 h at 4◦C (Figure 2A). Switching
to RT, both BgAg and Ag maintained potent efficacy against
P. aer over a period of 120 h. By contrast, Bg displayed little
inhibition at any time point (Figure 2B). In keeping with
previous agar diffusion results (Figure 1), no S. aureus growth
inhibition was observed following treatment with pre-incubated
Bg at 4◦C or RT (Figures 2C,D). By contrast BgAg and Ag
maintained efficacy against S. aureus over 120 h at both 4◦C and
RT (Figures 2C,D). An alternative measure related to treatment
efficacy is the capacity to release antimicrobial over time. Here,
FIGURE 2 | Bioactive glass incorporating silver maintains stability and releases soluble antimicrobial factors over a clinically relevant time frame. Bg, Ag, and BgAg,
pre-incubated at 4◦C (A) and RT (B) prior to 24-h agar diffusion assays, showed differential antimicrobial efficacy against P. aeruginosa. BgAg and Ag caused
significant S. aureus growth inhibition at 4◦C (C) and RT (D). Kinetic testing revealed release of soluble antimicrobial factors from BgAg, with potent antimicrobial
effectiveness against P. aeruginosa (E) and S. aureus (F). Points show the mean ± SEM. ∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001. Data were obtained from three
independent experiments (n = 3 per treatment).
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the kinetics of release was measured by serial incubation of Bg,
Ag, or BgAg in PBS over six consecutive periods of 24 h. Here, Bg
and Ag showed no antimicrobial efficacy against P. aeruginosa
or S. aureus at any time point (Figures 2E,F). BgAg, however,
strongly inhibited the growth of P. aeruginosa and S. aureus
for up to 96 h (Figures 2E,F). Collectively, these data show
that both Ag and BgAg are highly stable, while BgAg alone is
able to release soluble antimicrobial factors over a 4-day time
frame.
Biofilm Formation Was Impaired by BG
Treatment, With Differential
Effectiveness Against P. aeruginosa,
S. aureus, and Co-cultured Bacteria
Given the potent effects of Bg and BgAg against planktonic
bacteria, we next asked whether Bg or BgAg were able to inhibit
the formation of biofilms (microtiter method at OD495 nm;
Table 1). In the absence of treatment, P. aeruginosa was
considerably more effective at forming biofilm than S. aureus,
or co-cultured bacteria (Table 2), which reflects previous studies
(Bose et al., 2012; Nguyen and Oglesby-Sherrouse, 2016).
S. aureus biofilm formation was entirely inhibited by 0.625%
BgAg, while Bg treatment at the same concentration had no
effect on S. aureus biofilm formation. For P. aeruginosa, both
Bg and BgAg strongly inhibited biofilm formation at higher
concentration (0.625%). However, at the lower 0.15%, only BgAg
was able to partially inhibit biofilm formation. These results were
recapitulated in co-culture, where 0.625% Bg had little effect on
biofilm formation, while 0.625% BgAg strongly inhibited biofilm
formation. Taken together these data reveal greater anti-biofilm
efficacy for BgAg than Bg alone.
BgAg Reduces Both P. aeruginosa and
S. aureus Biofilms in an ex Vivo Porcine
Wound Model
To more faithfully replicate the in vivo environment, we
turned to a combined ex vivo porcine skin/established bacterial
biofilm model. Here, viable porcine wound explants were
cultured following apical surface inoculation with established
P. aeruginosa or S. aureus biofilms (Figure 3). Treatment
for 24 h with Bg, BgAg, or Ag alone led to a visible
reduction in biofilm thickness. Representative images illustrate
biofilms visualized using Gram-Twort (P. aeruginosa, pink;
S. aureus, purple; Figures 3A,D), ConA (Figures 3B,E), and AO
(Figures 3C,F). Quantification of biofilm thickness from Gram-
Twort stained sections across multiple replicates revealed that
BgAg treatment alone led to a statistically significant reduction in
biofilm thickness (Figures 3G,H). Post-treatment viable colony
enumeration (CFU/ml) was performed in parallel on dissociated
biofilms. Here, all three treatments significantly reduced the
number of viable biofilm bacteria (P. aeruginosa and S. aureus
biofilms; Figures 3I,J), with BgAg showing greatest efficacy
against both bacterial species. These data directly demonstrate
that silver-functionalized bioactive glass is effective against
established ex vivo biofilms.
Bg, BgAg, and Ag Treatments
Differentially Influence P. aeruginosa
Biofilm Virulence Factor Production
Bacterial colony enumeration alone does not directly convey
bacterial pathogenicity (reviewed in Kallstrom, 2014), and
effective invasion and adherence are fundamental requirements
for establishing wound tissue infection (reviewed in Percival
and McCarty, 2015). Thus, biofilm virulence was investigated
via quantitative evaluation of extracellular protease activity and
analysis of candidate virulence gene expression. In P. aeruginosa,
these virulence factors include the endoproteases elastase (LasB)
and alkaline protease (AprA), and alginate (AlgD; Goodman and
Lory, 2004; Chu et al., 2016).
Zymography was performed to elucidate changes in bacterial
protease activity (Figure 4). P. aeruginosa biofilm samples
gave a range of bands on a gelatin zymogram (original gel,
Supplementary Figure S1). Quantification was performed for the
principle bands (∼70 and ∼50 kDa) in addition to total activity.
Protease activity depicted by band 1 (∼70 kDa), described as a
distinct version of elastase (Lomholt et al., 2001), was significantly
inhibited by BgAg compared to the vehicle (Figures 4A,B),
but not Bg or Ag alone. A different pattern of activity, where
both Bg and BgAg reduced expression compared to the vehicle
control, was observed for band 2 (∼50 kDa), which corresponds
to the molecular mass of alkaline protease activity (Caballero
et al., 2001; Lomholt et al., 2001; Figures 4A,C). Finally, when
total protease activity within each lane was measured, BgAg
and Bg significantly inhibited protease activity (Figures 4A,D).
Independent colorimetric protease analysis, using the Azocasein
method (Andrejko et al., 2013) was performed to quantify total
biofilm protease activity following treatment (Figure 4E). Here,
total protease activity was significantly reduced following BgAg
treatment alone, compared to the vehicle.
TABLE 2 | The effects of bioactive glass (Bg) and Bg with silver (BgAg) on single-species and co-culture biofilm formation, based on OD measurements at 495 nm.
Treatment S. aureus NCTC 13297 P. aeruginosa NCTC 10781 Co-culture
Concentration Mean OD Biofilm Concentration Mean OD Biofilm Concentration Mean OD Biofilm
Bacteria 0.1 Moderate 0.54 Strong 0.14 Moderate
BgAg 0.625% 0.04 Non-adherent 0.625% 0.08 Weak 0.625% 0.06 Weak
0.15% 0.1 Moderate 0.15% 0.23 Strong 0.15% 0.09 Moderate
Bg 0.625% 0.11 Moderate 0.625% 0.07 Weak 0.625% 0.09 Moderate
0.15% 0.1 Moderate 0.15% 0.5 Strong 0.15% 0.11 Moderate
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FIGURE 3 | Bioactive glass reduces biofilm load and bacterial viability in an ex vivo porcine wound biofilm model. Modified Gram-Twort staining illustrated a
reduction in P. aeruginosa (P. aer; pink; A) and S. aureus (S. aur; purple; D) biofilm load (black arrows), on porcine skin (blue) following Bg, BgAg and Ag treatment.
Quantification of Gram-Twort biofilm thickness (n = 9 images per treatment) showed a significant reduction in P. aeruginosa (G) and S. aureus (H) following BgAg
treatment only. Similarly, Concanavalin A (blue biofilm, B,E) and Acridine Orange (red biofilm, C,F) staining demonstrated decreased P. aeruginosa (B,C) and
S. aureus (E,F) biofilm (depicted by white arrows) following bioactive glass treatment. Biofilm was not apparent on uninoculated porcine wounds. Bg, BgAg and Ag
also significantly reduced P. aeruginosa (I) and S. aureus (J) porcine biofilm load (CFU/ml) within 24 h of treatment (n = 3 biopsies per treatment). Black scale
bars = 10 µm, white scale bars = 20 µm. Bars show mean ± SEM. ∗P < 0.05 and ∗∗∗P < 0.001.
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FIGURE 4 | Extracellular protease activity from P. aeruginosa (P. aer) biofilms is differentially altered by bioactive glass treatment. Zymography analysis (A–D)
illustrated changes in protease activity, where each lane showed P. aeruginosa biofilm (P. aer), vehicle (Veh), Bg, BgAg, and Ag treatments, respectively (lanes were
cut and placed in this order, as shown via a white dotted line, representative of three gels). Significantly dampened activity of the protease in band 1 (∼70 kDa; A,B)
was shown following BgAg treatment, while both Bg and BgAg significantly reduced protease activity in band 2 (∼50 kDa, A,C), and overall protease action (D),
compared to Veh. Colorimetric analysis (repeated in three independent experiments) of total extracellular protease (E) demonstrated a reduction in proteolytic activity
with BgAg, compared to Veh. Significant reductions (compared to Veh) were also observed in expression of the virulence genes lasB (F) and aprA (G), while no
significant changes were shown in algD (H), illustrated via RT-qPCR. Data represent the mean ± SEM. ∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001.
We next switched to evaluating virulence factor gene
expression in P. aeruginosa biofilms. Analysis revealed that all
three treatments significantly reduced expression of the gene
lasB compared to Veh (P < 0.05, Figure 4F), important in
encoding elastase B production (Casilag et al., 2016). Similarly,
Ag significantly reduced aprA expression (P < 0.01), a gene
encoding alkaline protease (Lomholt et al., 2001; Figure 4G),
while Bg and BgAg treatment led to a further reduction in aprA
expression (P < 0.001). Finally, reduced expression of algD
(important for alginate biosynthesis; Wiens et al., 2014) was
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apparent following Bg and BgAg treatment, although this failed
to reach significance (Figure 4H).
BgAg Protects Porcine Tissue From
Biofilm Induced Dermal Cell Death and
ECM Turnover
We next switched our attention to assessing the direct effects
of bacterial biofilm exposure on porcine wound tissue. Initial
histological evaluation of non-biofilm infected skin revealed
comparable levels of cell proliferation prior to culture (4%)
versus after 48 h of ex vivo culture (3%; Figure 5D),
agreeing with previously published data (Yeung et al., 2016).
Similarly, only a marginal increase in cell death was observed
following 48 h of ex vivo culture, with around 20% of cells
TUNEL+ve (Figures 5B,E) and around 5% of cells undergoing
apoptosis (caspase 3+ve; Figures 5C,F). In stark contrast,
skin that was maintained ex vivo for 48 h in the presence
of biofilm displayed significantly high levels of decellularity
compared to pre-cultured tissue (Figures 5G,H). Notably, Bg
FIGURE 5 | Viability of porcine explants is drastically reduced by biofilm treatment, yet BgAg prevents decellularization. Viability of uninoculated porcine tissue over
the 48-h culture period was assessed via comparison of wounds pre-culture (“Pre”) and post-culture (“Post”) at 37◦C and 5% CO2 (n = 3 per group). Viability was
deduced via visualization of structure (A, Masson’s trichrome staining), cell proliferation (Ki67+ve staining, D), cell viability (TUNEL-ve cells, blue, B and E) and
apoptosis (caspase 3+ve cells, green, C and F). Cell death following P. aeruginosa (P. aer, G) and S. aureus (S. aur, H) biofilm loading was assessed by measuring
cellularity (number of DAPI stained cells per mm2) post-culture (48 h, n = 9 images per group). Cellularity of pre-culture porcine tissue was also assessed. Arrows
depict positively stained green cells. Black bars = 100 µm, white bars = 20 µm. White arrows depict green (apoptotic) cells. ∗P < 0.05, ∗∗ P < 0.01, ∗∗∗P < 0.001.
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treatment significantly reduced this biofilm-induced cell lysis
in P. aeruginosa inoculated wounds (Figure 5G), while BgAg
retained increased cellularity compared to biofilm controls.
Finally, given the effects of bioactive glass treatment on bacterial
protease production (Figure 4), we asked whether changes in skin
extracellular matrix composition would be evident. Interestingly,
biofilm infection increased collagen turnover at the biofilm skin
interface [visualized by an increase in new (green birefringence)
fiber production; Figure 6]. Again, treatment with Bg, BgAg,
and Ag decreased this turnover in wounds inoculated with
P. aeruginosa biofilms, reducing the amount of new matrix
produced (Figures 6A,C). Interestingly, in S. aureus wounds,
BgAg treatment alone maintained a protective effect against
collagen turnover (Figures 6B,C). Thus, Bg treatment is not
only effective at killing biofilm bacteria, but it also demonstrably
reduces the direct detrimental effects of bacteria on the host
tissue.
Disparate Anti-biofilm Effects of BG on
P. aeruginosa: S. aureus Co-culture
Porcine Wound Biofilms
The prevalence of polymicrobial infections is a major clinical
problem, which contributes to the intransigent nature of
chronic wounds (Pastar et al., 2013; Fleming et al., 2017).
To partially mimic this phenomenon, we established a co-
culture porcine wound biofilm model. Interestingly, all three
treatments were less effective at killing bacteria in co-cultured
biofilms than in single culture biofilms (Figure 3). These
effects were confirmed by direct visualization of the co-culture
biofilms, where Bg, BgAg, and Ag treatment led to no more
than a mild qualitative reduction in wound biofilm load
via Gram-Twort (Figure 7B), ConA (Figure 7C), and AO
staining (Figure 7D). Quantification of biofilm thickness revealed
only a non-significant trend toward reduced biofilm thickness
following treatments (Figure 7A). We did, however, observe
a statistically significant reduction in total CFU following Bg,
BgAg, and Ag treatment of co-cultured biofilms (Figure 7E).
Overall, these data demonstrated a less pronounced effect of
Bg and BgAg against co-culture biofilms than single-species
biofilms.
More clinically significant was the effect of treatments on the
relative proportion of P. aeruginosa and S. aureus in co-cultured
biofilms (Figure 7F). At the time of collection (48 h post tissue
inoculation), vehicle-treated biofilms were quantified as 55:45
P. aeruginosa to S. aureus relative proportions. Ag treatment
led to a modest non-significant shift in these proportions to
around 65:35. By contrast, Bg treatment led to a large, statistically
significant shift to almost 90:10 (P < 0.05, in both P. aeruginosa
and S. aureus contribution). The greatest effect was observed
following BgAg treatment, where virtually no S. aureus could be
recovered (P < 0.01, in P. aeruginosa and S. aureus). These data,
which mirror the differential selectivity of BG treatment against
single-species biofilms (Figure 3), reveal the extent to which
a topical wound treatment can alter the dynamic equilibrium
between two bacterial species.
FIGURE 6 | Bioactive glass protects against extracellular matrix turnover. Picrosirius red staining of porcine biofilm tissue (n = 9 per group) demonstrated changes in
collagen III turnover via measurement of % green: red fibers (green birefringence is demonstrated by white arrows). Significantly more collagen III turnover was
demonstrated in P. aeruginosa (P. aer, A,C) biofilms compared to uninoculated controls, Bg and Ag treatments. S. aureus (S. aur, B,C) biofilms increased collagen III
turnover compared to BgAg and uninoculated porcine explants. ∗P < 0.05, ∗∗P < 0.01. White bars = 100 µm.
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FIGURE 7 | Co-culture biofilms of P. aeruginosa (P. aer) and S. aureus (S. aur) appear more resistant to bioactive glass than single-species biofilms. Quantification of
biofilm thickness (A; n = 9 images per group) via Gram-Twort staining (B), revealed no significant change in biofilm load (black arrows) with bioactive glass treatment.
Further visualization with Concanavalin A (C, blue biofilms), and Acridine Orange (D, red biofilms, above the white-dotted line) confirmed this, where white arrows
illustrate biofilms. However, Bg, silver Bg (BgAg), and silver alone (Ag) caused a significant reduction in porcine biofilm load (CFU/ml) within 24 h (E). The percentage
of P. aeruginosa and S. aureus contributing to the co-culture porcine biofilms was also determined following treatment, where statistical analysis shows significant
changes in the contribution of P. aeruginosa and S. aureus between treatments (F). Black scale bars = 10 µm, white scale bars = 20 µm. Bars show the
mean ± SEM. ∗P < 0.05, ∗∗P < 0.01, and ∗∗∗P < 0.001.
DISCUSSION
Though it is axiomatic that silver has potent antimicrobial effects
against a range of bacterial species (reviewed in Maillard and
Hartemann, 2013), comparatively few studies have addressed the
antimicrobial and anti-biofilm efficacy of BG formulations. Fewer
still have explored BG formulations functionalized with silver
(e.g., Drago et al., 2014; Gholipourmalekabadi et al., 2016). Here,
we assessed the bactericidal activity of BG against planktonic
and biofilm forms of wound-relevant bacteria (P. aeruginosa
and S. aureus; James et al., 2008). Our data clearly show
that BG incorporating silver (BgAg) provided a more potent
bactericidal effect against planktonic P. aeruginosa and S. aureus
than Bg or Ag alone. Previously, Ag treatment has been
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shown to increase membrane permeability and potentiate the
susceptibility of Gram-negative bacteria to antibiotics (Morones-
Ramirez et al., 2013). Therefore, in the present work, Ag may
also be potentiating microbial susceptibility to bioactive glass.
An important novel observation was the relative species-specific
efficacy, with Bg more effective against planktonic P. aeruginosa
than S. aureus (Figure 1). In agar diffusion tests, Bg alone
failed to cause inhibition of S. aureus growth. One previously
suggested reason for this is that bacterial metabolism (acid
production) may circumvent increased pH, thus reduce the
diffusibility of Bg into agar (Stoor et al., 1998; Martins et al.,
2011). However, the observed differential effects of Bg most
likely reflect the differences in cell-wall structure between the two
bacterial species. The Gram-positive S. aureus is encapsulated by
a thickened peptidoglycan cell wall which has been suggested
to convey increased resistance (Zoeiby et al., 2001). Indeed,
a number of S. aureus strains maintain antibiotic-tolerance
via cell wall-related mechanisms (Utaida et al., 2003; Dengler
et al., 2011). The less substantial P. aeruginosa cell wall and
membrane structure may confer susceptibility to the increased
pH caused by Bg ion dissolution (e.g., [Ca2+]i and [Na+]i release;
Stoor et al., 1998), thus altering bacterial membrane potential
(Munukka et al., 2008) and causing osmotic stress (Van der
Waal et al., 2011). Furthermore, regional variation in skin pH
is thought to play a significant role in spatial localisation of
skin bacteria (reviewed in Schreml et al., 2010), while S. aureus
is known to favor more acidic conditions than P. aeruginosa
(Ushijima et al., 1984). In the present study, the effects of BG
may also be due to the antimicrobial efficacy of its relative
components, e.g., SiO2 (Maçon et al., 2017; Siqueira et al.,
2017).
Of more physiological relevance, BG significantly reduced
P. aeruginosa and S. aureus biofilm load in an ex vivo porcine
wound explant model, albeit less effectively than during in vitro
planktonic assays (Figure 3). Curiously, species-specific efficacy
was reversed in this biofilm model, with S. aureus more
susceptible to BG treatment than P. aeruginosa. This may simply
reflect the strong biofilm-producing ability of P. aeruginosa
(Harrison-Balestra et al., 2003) accompanied by production of
a multitude of extracellular proteases (Andrejko et al., 2013).
By contrast, S. aureus forms weak biofilms initially, relying on
adhesion proteins and autolysin production for its virulence and
biofilm generation (Rice et al., 2007; Bose et al., 2012; Foulston
et al., 2014). S. aureus favors acidic conditions in the clinical
setting (Weinrick et al., 2004), and a well characterized drop in
pH triggers S. aureus biofilm matrix production and subsequent
cell aggregation. As BG treatment increases pH (∼10 in the
present study, data not shown), we postulate that alkaline stress
caused by BG could contribute to reduced biofilm load. Here
the literature is conflicting with respect to S. aureus; Foulston
et al. (2014) report reduced biofilm formation at high pH,
while Van der Waal et al. (2011) report no effect on biofilm
viability.
The most common method for determining bacterial load
in samples is through assessing colony viability (Buysschaert
et al., 2016). However, recent evidence suggests some bacteria,
including P. aeruginosa and S. aureus, can enter a viable but not
culturable (VBNC) state, where they may contribute to biofilm
virulence (Zhang et al., 2015). Alterations in exogenous stimuli
are known to modify P. aeruginosa virulence factor expression
(Rumbaugh et al., 1999; Shigematsu et al., 2001; Breidenstein
et al., 2011), largely through quorum-sensing systems (Dong
and Zhang, 2005). In quantifying virulence factor expression,
we focused on genes responsible for modulating protease
production and bacterial cell–host matrix binding, fundamental
requirements for establishing wound tissue infection (reviewed
in Percival and McCarty, 2015). Bg, BgAg, and Ag significantly
reduced expression of the P. aeruginosa virulence factors; elastase
(LasB) and alkaline protease (AprA; Goodman and Lory, 2004;
Lee et al., 2013; Khosravi et al., 2016). Direct analysis of
P. aeruginosa gelatinases confirmed the effect of bioactive glass,
where Bg and BgAg demonstrated a substantial reduction in
activity corresponding to elastase (∼37 kDa; Miyajima et al.,
2001) and alkaline protease (50–75 kDa; Engel et al., 1997;
Schmidtchen et al., 2003; Figure 4). Elastase (LasB) is particularly
interesting as it exhibits potent widespread proteolytic activity,
thus causing excessive wound tissue proteolysis (Kessler et al.,
1998) while preventing normal dermal fibroblast growth
(Schmidtchen et al., 2003). Indeed, when we assessed the effect
of P. aeruginosa and S. aureus biofilms on host tissue we found
reduced cellularity and increased matrix turnover (Figures 5, 6,
respectively).
Chronic wounds are a term used to encompass all wounds
that fail to heal within 12 weeks and can include, but are not
limited to, diabetic foot ulcers, pressure sores, and venous leg
ulcers (Rodriguez-Arguello et al., 2018). Chronic wounds often
remain recalcitrant due to their diverse microbial communities
(Gardner et al., 2013; Kalan et al., 2016), which can profoundly
affect clinical outcome (Baldan et al., 2014; Wolcott et al., 2015).
Although the consequences of interspecies interactions on wound
pathogenesis remain to the elucidated, experimental studies have
revealed that multiple-species biofilms exert major influence
on host tissue responses, such as inflammation (Pastar et al.,
2013). Therefore, we produced co-culture porcine biofilms of
S. aureus and P. aeruginosa to further investigate the efficacy
of BG treatment. Our experiments also revealed that co-
cultured biofilms were more resistant to BG treatment, where
only a modest reduction in viability was observed (Figure 7).
Experimentally producing polymicrobial biofilm communities
can be difficult as one species often predominates (Malic et al.,
2009; Dalton et al., 2011). In our study, untreated porcine biofilms
adopted a stable ratio at around 60:40 P. aeruginosa to S. aureus,
in line with the potentially synergistic relationship between the
two species (Dalton et al., 2011; Korgaonkar et al., 2013; Pastar
et al., 2013). Curiously, following BG-treatment, P. aeruginosa
quickly became dominant. This supports studies demonstrating
that P. aeruginosa may out-compete S. aureus when resources
are limited, in part by sequestering vital cofactors, and producing
metabolites toxic to S. aureus (Mashburn et al., 2005; Biswas et al.,
2009; DeLeon et al., 2014).
Collectively, this study demonstrates clear potential for Bg and
BgAg as potential wound-relevant antimicrobials. It is crucial that
we continue to explore novel antimicrobial agents, especially for
indications where mechanisms of antibiotic resistance and silver
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resistance are a concern (Su et al., 2011; Randall et al., 2015). This
is particularly important when considering the polymicrobial
interactions of clinical infections (Dalton et al., 2011). Although
not addressed in the present study, BG presents an attractive
opportunity for future functionalization with a variety of
compounds designed to promote wound repair (Bonvallet et al.,
2015; Wu et al., 2017). Combining this versatility with clear
antimicrobial efficacy offers exciting opportunities for wound
management.
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